CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.

Mutation

CIViC ID: 29 · Gene: CEBPA

Variant Summary

HGVS
Variant Type(s)
loss_of_function_variant,transcript_variant
Evidence Items
11

Evidence Level Distribution

Level B: 10Level D: 1

Evidence Items

Showing CIViC evidence rows where gene = CEBPA and variant = Mutation.

LevelTypeDirectionSignificanceDiseaseDrugsRating
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated CEBPA4
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated CEBPA4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia With Mutated CEBPA4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia4
BDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated CEBPA3
BPredictiveDoes Not SupportSensitivity/ResponseAcute Myeloid LeukemiaTretinoin3
DDiagnosticSupportsPositiveAcute Myeloid Leukemia With Mutated CEBPA3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3
BPrognosticSupportsBetter OutcomeAcute Myeloid Leukemia3